| # | % | |||||
|---|---|---|---|---|---|---|
| 251 | CONATUS PHARMACEUTICALS INC COM | 156,531 | 446,000 | 0.01% | ||
| 252 | SANTANDER CONSUMER USA HDG I COM | 26,348 | 418,000 | 0.01% | ||
| 253 | PROSPERITY BANCSHARES INC | 8,682 | 416,000 | 0.01% | ||
| 254 | VITAE PHARMACEUTICALS INC | 22,608 | 409,000 | 0.01% | ||
| 255 | ALKERMES PLC SHS | 4,547 | 361,000 | 0.01% | ||
| 256 | TOBIRA THERAPEUTICS INC | 34,061 | 342,000 | 0.01% | ||
| 257 | LEXICON PHARMACEUTICALS | 25,000 | 333,000 | 0.01% | ||
| 258 | OCULAR THERAPEUTIX INC | 35,000 | 328,000 | 0.01% | ||
| 259 | QIWI PLC | 17,317 | 311,000 | 0.01% | ||
| 260 | NRG YIELD INC | 20,342 | 283,000 | 0.01% | ||
| 261 | NET 1 UEPS TECHNOLOGIES INC | 19,593 | 265,000 | 0.00% | ||
| 262 | ProQR Therapeutics NV | 30,000 | 260,000 | 0.00% | ||
| 263 | WISDOMTREE INVTS INC | 14,950 | 234,000 | 0.00% | ||
| 264 | VERMILLION INC | 100,000 | 180,000 | 0.00% | ||
| 265 | Nabriva Therapeutics AG | 10,934 | 104,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-002788, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
